Evan Rosenbaum

1.1k total citations
34 papers, 419 citations indexed

About

Evan Rosenbaum is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Evan Rosenbaum has authored 34 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Evan Rosenbaum's work include Sarcoma Diagnosis and Treatment (17 papers), Vascular Tumors and Angiosarcomas (10 papers) and CAR-T cell therapy research (10 papers). Evan Rosenbaum is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Vascular Tumors and Angiosarcomas (10 papers) and CAR-T cell therapy research (10 papers). Evan Rosenbaum collaborates with scholars based in United States, Italy and United Kingdom. Evan Rosenbaum's co-authors include William D. Tap, Cristina R. Antonescu, Samuel Singer, Bin Xu, Sandra P. D’Angelo, Narasimhan P. Agaram, Bhumika Jadeja, William D. Travis, Lei Zhang and Ping Chi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Evan Rosenbaum

31 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Rosenbaum United States	12	258	194	73	62	62	34	419
Michael J. Nathenson United States	14	232 0.9×	292 1.5×	59 0.8×	50 0.8×	60 1.0×	29	453
Isabelle Laure Ray-Coquard France	15	625 2.4×	235 1.2×	131 1.8×	155 2.5×	103 1.7×	110	852
Kanae Nosaka Japan	12	153 0.6×	135 0.7×	29 0.4×	178 2.9×	48 0.8×	36	425
Xuefei Jia United States	11	316 1.2×	281 1.4×	86 1.2×	80 1.3×	22 0.4×	25	527
Michał Wągrodzki Poland	14	221 0.9×	395 2.0×	69 0.9×	59 1.0×	33 0.5×	40	510
Małgorzata Babińska Poland	12	94 0.4×	233 1.2×	43 0.6×	133 2.1×	77 1.2×	20	394
Charles H. Pippitt United States	8	139 0.5×	57 0.3×	42 0.6×	155 2.5×	70 1.1×	14	356
Sarasa T. Kim United States	13	114 0.4×	155 0.8×	26 0.4×	89 1.4×	29 0.5×	16	457
Sonja Chen United States	11	152 0.6×	366 1.9×	100 1.4×	101 1.6×	127 2.0×	37	537
Seog-Yun Park South Korea	10	170 0.7×	172 0.9×	22 0.3×	138 2.2×	84 1.4×	22	433

Countries citing papers authored by Evan Rosenbaum

Since Specialization

Citations

This map shows the geographic impact of Evan Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Rosenbaum more than expected).

Fields of papers citing papers by Evan Rosenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Rosenbaum. The network helps show where Evan Rosenbaum may publish in the future.

Co-authorship network of co-authors of Evan Rosenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Rosenbaum. A scholar is included among the top collaborators of Evan Rosenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Rosenbaum. Evan Rosenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bradić, Martina, Barbara O’Malley, Irina Linkov, et al.. (2025). Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade. npj Precision Oncology. 9(1). 85–85.

Kelly, Ciara M., Viswatej Avutu, Lauren B. Banks, et al.. (2024). Phase I trial of CRD3874-SI, a systemically administered STING agonist, in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2690–TPS2690. 2 indexed citations

Dermawan, Josephine K., M. Gabriela Kuba, Aimeé M. Crago, et al.. (2024). Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma. Genes Chromosomes and Cancer. 63(5). e23240–e23240. 3 indexed citations

Rosenbaum, Evan, Kenneth Seier, Martina Bradić, et al.. (2023). Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Research Communications. 3(10). 2118–2125. 6 indexed citations

Lebow, Emily S., Stephanie Lobaugh, Zhigang Zhang, et al.. (2023). Stereotactic body radiation therapy for sarcoma pulmonary metastases. Radiotherapy and Oncology. 187. 109824–109824. 4 indexed citations

Rosenbaum, Evan, Li‐Xuan Qin, Mark A. Dickson, et al.. (2023). Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS).. Journal of Clinical Oncology. 41(16_suppl). 11518–11518. 3 indexed citations

Bartlett, Edmund K., Kenneth Seier, Cristina R. Antonescu, et al.. (2022). Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma. JCO Precision Oncology. 6(6). e2200087–e2200087. 4 indexed citations

Kuba, M. Gabriela, Josephine K. Dermawan, Bin Xu, et al.. (2022). Histopathologic Grading Is of Prognostic Significance in Primary Angiosarcoma of Breast. The American Journal of Surgical Pathology. 47(3). 307–317. 14 indexed citations

Rosenbaum, Evan, Li‐Xuan Qin, Katherine A. Thornton, et al.. (2022). A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS).. Journal of Clinical Oncology. 40(16_suppl). 11516–11516. 5 indexed citations

10.

Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome. Clinical Cancer Research. 26(20). 5448–5455. 12 indexed citations

11.

Hensley, Martee L., Shweta S. Chavan, David B. Solit, et al.. (2020). Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clinical Cancer Research. 26(14). 3881–3888. 67 indexed citations

12.

Rosenbaum, Evan, Philip Jonsson, Kenneth Seier, et al.. (2020). Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO Precision Oncology. 4(4). 1350–1360. 26 indexed citations

13.

Rosenbaum, Evan, Kenneth Seier, Chaitanya Bandlamudi, et al.. (2020). HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome.. Journal of Clinical Oncology. 38(15_suppl). e23560–e23560.

14.

Rosenbaum, Evan, Bhumika Jadeja, Bin Xu, et al.. (2019). Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Modern Pathology. 33(4). 591–602. 97 indexed citations

15.

Roberts, Emily, Maryann Shango, Brian G. Till, et al.. (2019). Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States. British Journal of Haematology. 186(2). 255–262. 17 indexed citations

16.

Rosenbaum, Evan, Ciara M. Kelly, Sandra P. D’Angelo, et al.. (2019). A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor. The Oncologist. 24(10). 1309–e983. 32 indexed citations

17.

Ruff, Paul, Herbert Cubasch, Maureen Joffe, et al.. (2018). Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa. Cancer Management and Research. Volume 10. 279–286. 10 indexed citations

18.

Sarfaty, Michal, et al.. (2018). A cost-effectiveness analysis of Nivolumab and Ipilimumab versus Sunitinib in first line intermediate-poor risk advanced Renal Cell Carcinoma. European Urology Supplements. 17(14). e2941–e2941. 1 indexed citations

19.

Cubasch, Herbert, Maureen Joffe, Paul Ruff, et al.. (2017). Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS ONE. 12(8). e0182125–e0182125. 16 indexed citations

20.

Rosenbaum, Evan, et al.. (1971). Comparative studies of lymph and lymphocytes of the thoracic duct and right lymphatic duct. I. Normal dogs.. PubMed. 4(2). 53–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact